News
-
-
PRESS RELEASE
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to present additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, reinforcing potential in Progressive Multiple Sclerosis. Latest research findings to be shared at event -
-
-
-
-
-
PRESS RELEASE
Conference call on the results for the 1st quarter 2025/2026 (ending 31 December 2025) on 11 February 2026
DOUGLAS Group invites you to a conference call on the results for the 1st quarter 2025/2026 on 11 February 2026, highlighting their position as Europe's top omnichannel beauty destination -
-
PRESS RELEASE
From Banks of Yellow River to Dining Tables Worldwide: Lanzhou Beef Noodles Get a Makeover through Cross-industry Fusion
Lanzhou Beef Noodles industry sees significant growth through cross-sector integration, reaching 80 billion yuan revenue in 2025, driven by diversified revenue streams and cultural IP development